Effectiveness of Adherence Therapy in Adults with Type 2 Diabetes: A Systematic Review

Fatimah Alenazi, Daniel Bressington, Monika Shrestha, Monica Peddle and Richard Gray
Additional contact information
Fatimah Alenazi: School of Nursing and Midwifery, La Trobe University, Bundoora 3086, Australia
Daniel Bressington: College of Nursing and Midwifery, Charles Darwin University, Ellengowan Drive, Casuarina 0810, Australia
Monika Shrestha: School of Nursing and Midwifery, La Trobe University, Bundoora 3086, Australia
Monica Peddle: School of Nursing and Midwifery, La Trobe University, Bundoora 3086, Australia
Richard Gray: School of Nursing and Midwifery, La Trobe University, Bundoora 3086, Australia

IJERPH, 2021, vol. 18, issue 9, 1-12

Abstract: Adherence therapy has been shown to be an effective adjunct treatment in long-term conditions including hypertension. The purpose of this study is to review and critically appraise evidence on the effectiveness of adherence therapy as an intervention in adults with type 2 diabetes. A systematic search of clinical trials published between 2005 and January 2020 in databases was undertaken in October 2018 and updated in August 2020. Inclusion criteria were any clinical trials where the population under investigation was adults with type 2 diabetes and the experimental intervention was adherence therapy. Version 2 of the Cochrane risk of bias was used to determine the quality of the included studies. No studies met our inclusion criteria. However, four studies that we excluded at full text screening tested some of the components (e.g., problem solving) of adherence therapy. As is recommended when reporting empty reviews, those studies were synthesized to determine if useful information can be extracted. That no trials of adherence therapy have been reported in type 2 diabetes establishes a potentially important gap in knowledge. This review was registered in PROSPERO (registration number: CRD42019115216) after the initial searches were completed.

Keywords: medication adherence; compliance; type 2 diabetes; diabetes educator; systematic review (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/18/9/4397/pdf (application/pdf)
https://www.mdpi.com/1660-4601/18/9/4397/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:18:y:2021:i:9:p:4397-:d:540186

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().